Venky Soundararajan
Overview
Explore the profile of Venky Soundararajan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
795
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Matson R, Comba I, Silvert E, Niesen M, Murugadoss K, Patwardhan D, et al.
NPJ Syst Biol Appl
. 2024 Nov;
10(1):138.
PMID: 39604453
Understanding which viral variants evade neutralization is crucial for improving antibody-based treatments, especially with rapidly evolving viruses like SARS-CoV-2. Yet, conventional assays are labor intensive and cannot capture the full...
2.
Ghosh P, Niesen M, Pawlowski C, Bandi H, Yoo U, Lenehan P, et al.
iScience
. 2024 Jul;
27(8):110406.
PMID: 39081289
Post-COVID-19 conditions (long COVID) has impacted many individuals, yet risk factors for this condition are poorly understood. This retrospective analysis of 88,943 COVID-19 patients at a multi-state US health system...
3.
DuBrock H, Wagner T, Carlson K, Carpenter C, Awasthi S, Attia Z, et al.
Eur Respir J
. 2024 Jun;
64(1).
PMID: 38936966
Background: Early diagnosis of pulmonary hypertension (PH) is critical for effective treatment and management. We aimed to develop and externally validate an artificial intelligence algorithm that could serve as a...
4.
Awasthi S, Sachdeva N, Gupta Y, Anto A, Asfahan S, Abbou R, et al.
EClinicalMedicine
. 2023 Dec;
65:102259.
PMID: 38106563
Background: Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death worldwide, driven primarily by coronary artery disease (CAD). ASCVD risk estimators such as the pooled cohort equations (PCE) facilitate...
5.
Silvert E, Hester L, Ramudu E, Pawlowski C, Kranenburg B, Buadi F, et al.
Am J Hematol
. 2023 Jul;
98(9):E255-E258.
PMID: 37403432
No abstract available.
6.
Matson R, Niesen M, Levy E, Opp D, Lenehan P, Donadio G, et al.
Lancet Digit Health
. 2023 Mar;
5(4):e206-e216.
PMID: 36963910
Background: The emergency use authorisation of BNT162b2 (tozinameran; Comirnaty, Pfizer-BioNTech) for children aged 5-17 years has resulted in rapid vaccination in the paediatric population. However, there are few studies of...
7.
Niesen M, Matson R, Puranik A, OHoro J, Pawlowski C, Vachon C, et al.
PNAS Nexus
. 2023 Jan;
1(2):pgac042.
PMID: 36713312
As of 2021 November 29, booster vaccination against SARS-CoV-2 infection has been recommended for all individuals aged 18 years and older in the United States. A key reason for this...
8.
Puranik A, Lenehan P, OHoro J, Pawlowski C, Virk A, Swift M, et al.
PNAS Nexus
. 2023 Jan;
1(2):pgac058.
PMID: 36713311
COVID-19 vaccines are effective, but breakthrough infections have been increasingly reported. We conducted a test-negative case-control study to assess the durability of protection against symptomatic infection after vaccination with mRNA-1273....
9.
Murugadoss K, Niesen M, Raghunathan B, Lenehan P, Ghosh P, Feener T, et al.
PNAS Nexus
. 2023 Jan;
1(1):pgac018.
PMID: 36712796
Highly transmissible or immuno-evasive SARS-CoV-2 variants have intermittently emerged, resulting in repeated COVID-19 surges. With over 6 million SARS-CoV-2 genomes sequenced, there is unprecedented data to decipher the evolution of...
10.
Venkatakrishnan A, Anand P, Lenehan P, Ghosh P, Suratekar R, Silvert E, et al.
Sci Rep
. 2023 Jan;
13(1):257.
PMID: 36604461
The emergence of highly transmissible SARS-CoV-2 variants and vaccine breakthrough infections globally mandated the characterization of the immuno-evasive features of SARS-CoV-2. Here, we systematically analyzed 2.13 million SARS-CoV-2 genomes from...